1. Home
  2. PBYI vs ILPT Comparison

PBYI vs ILPT Comparison

Compare PBYI & ILPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • ILPT
  • Stock Information
  • Founded
  • PBYI 2010
  • ILPT 2017
  • Country
  • PBYI United States
  • ILPT United States
  • Employees
  • PBYI N/A
  • ILPT N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • ILPT Real Estate Investment Trusts
  • Sector
  • PBYI Health Care
  • ILPT Real Estate
  • Exchange
  • PBYI Nasdaq
  • ILPT Nasdaq
  • Market Cap
  • PBYI 152.4M
  • ILPT 174.6M
  • IPO Year
  • PBYI N/A
  • ILPT 2018
  • Fundamental
  • Price
  • PBYI $3.28
  • ILPT $3.29
  • Analyst Decision
  • PBYI Strong Buy
  • ILPT Buy
  • Analyst Count
  • PBYI 1
  • ILPT 2
  • Target Price
  • PBYI $7.00
  • ILPT $10.00
  • AVG Volume (30 Days)
  • PBYI 375.3K
  • ILPT 371.9K
  • Earning Date
  • PBYI 05-08-2025
  • ILPT 04-29-2025
  • Dividend Yield
  • PBYI N/A
  • ILPT 1.22%
  • EPS Growth
  • PBYI 143.51
  • ILPT N/A
  • EPS
  • PBYI 0.77
  • ILPT N/A
  • Revenue
  • PBYI $232,709,000.00
  • ILPT $441,992,000.00
  • Revenue This Year
  • PBYI N/A
  • ILPT $3.09
  • Revenue Next Year
  • PBYI N/A
  • ILPT $1.79
  • P/E Ratio
  • PBYI $4.25
  • ILPT N/A
  • Revenue Growth
  • PBYI 2.68
  • ILPT 0.61
  • 52 Week Low
  • PBYI $2.23
  • ILPT $2.45
  • 52 Week High
  • PBYI $4.13
  • ILPT $5.45
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 52.36
  • ILPT 55.89
  • Support Level
  • PBYI $3.14
  • ILPT $3.01
  • Resistance Level
  • PBYI $3.45
  • ILPT $3.41
  • Average True Range (ATR)
  • PBYI 0.19
  • ILPT 0.15
  • MACD
  • PBYI 0.01
  • ILPT 0.01
  • Stochastic Oscillator
  • PBYI 51.19
  • ILPT 44.44

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About ILPT Industrial Logistics Properties Trust of Beneficial Interest

Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.

Share on Social Networks: